ACCESS PHARMACEUTICALS, INC.

Company

ABEONA THERAPEUTICS INC.

Filed

April 1, 1996

Period of Report

December 31, 1995

Accession Number

0000950146-96-000501

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →